Aguo Cheng

Title: Innovations in Healthcare: The Pioneering Work of Inventor Aguo Cheng

Introduction

Aguo Cheng is an innovative inventor based in Beijing, China, who has made significant contributions to the field of microneedle technology, particularly through his development of a novel method for creating nanosized cannabidiol (CBD) suspensions. With a unique approach that enhances the solubility of CBD, Cheng's work stands out in the realm of pharmaceutical innovation.

Latest Patents

Cheng holds a patent for a "Dissolving Microneedle Containing Cannabidiol Suspension and Preparation Method Thereof." This patent introduces a nanonization method for CBD, which involves several key steps. The method begins with dissolving CBD in a suitable solvent to form a CBD-good solvent solution. This solution is then combined with an aqueous stabilizer solution to create a mixed solution, which is ultrasonicated before the good solvent is removed through rotary evaporation. This process results in a nanosized CBD suspension, characterized by a high solid content and enhanced solubilization properties. The stabilizers used in this method include poloxamer, tween, polyoxyethylene alkyl ether, polyvinyl pyrrolidone, hydroxypropyl methyl cellulose, and carboxymethyl chitosan.

Career Highlights

Aguo Cheng has worked at notable institutions, including the Technical Institute of Physics and Chemistry and Beijing Cas Microneedle Technology Ltd. His research and development work has focused on pushing the boundaries of microneedle technology to improve drug delivery systems, specifically in the context of cannabinoids. His innovative approach has opened new avenues for therapeutic applications of CBD in healthcare.

Collaborations

Cheng has collaborated with talented professionals in the field, including colleagues Yunhua Gao and Han Liu. Together, they have advanced the understanding and application of microneedle technology, contributing to developments that may significantly impact drug delivery methods.

Conclusion

Aguo Cheng's inventive efforts have placed him at the forefront of pharmaceutical innovation. His patented method for creating nanosized CBD suspensions represents a significant advancement in drug delivery systems, particularly for cannabinoids. As research and applications of his work continue to grow, Cheng's contributions to the field of microneedle technology are poised to have a lasting impact on healthcare solutions.